Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Tyra Biosciences, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
05/04/2023 8-K Quarterly results
03/22/2023 8-K Quarterly results
Docs: "Tyra Biosciences, Inc. Balance Sheet Data December 31, 2022 2021 Balance Sheet Data: Cash and cash equivalents $ 251,213 $ 302,182 Working capital 251,587 300,441 Total assets 266,181 306,701 Accumulated deficit Total stockholders’ equity 257,829 301,737 Tyra Biosciences, Inc. Statements of Operations and Comprehensive Loss Three Months Ended December 31, Year Ended December 31, 2022 2021 2022 2021 Operating expenses: Research and development $ 10,400 $ 7,250 $ 43,008 $ 20,636 General and administrative 4,618 2,682 15,919 5,652 Total operating expenses 15,018 9,932 58,927 26,288 Loss from operations Other income : Interest income 2,156 5 3,652 13 Other income Total other income 2,123 2 3,602 Net loss and comprehensive loss $ $ $ $ Net loss per share, basic and diluted $ $ $ $ Weight..."
03/01/2023 8-K Quarterly results
11/29/2022 8-K Other Events  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
11/03/2022 8-K Quarterly results
10/03/2022 8-K Quarterly results
08/04/2022 8-K Quarterly results
Docs: "Tyra Biosciences, Inc. Balance Sheet Data June 30, December 31, 2022 2021 Balance Sheet Data: Cash and cash equivalents $ 275,107 $ 302,182 Working capital 271,844 300,441 Total assets 287,118 306,701 Accumulated deficit Total stockholders’ equity 278,853 301,737 Tyra Biosciences, Inc. Statements of Operations and Comprehensive Loss Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Operating expenses: Research and development $ 12,047 $ 4,381 $ 21,692 $ 7,902 General and administrative 3,381 1,127 8,570 1,816 Total operating expenses 15,428 5,508 30,262 9,718 Loss from operations Other income : Interest income 346 4 364 5 Other expense Total other income 333 341 Net loss and comprehensive loss $ $ $ $ Net loss per share, basic and diluted $ $ $ $ Weighted-aver..."
06/14/2022 8-K Quarterly results
05/05/2022 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Tyra Biosciences Reports First Quarter 2022 Financial Results and Highlights"
03/03/2022 8-K Quarterly results
11/03/2021 8-K Quarterly results
Docs: "Tyra Biosciences Reports Third Quarter 2021 Financial Results and Highlights"
09/17/2021 8-K Quarterly results

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy